Global Immuno-oncology Diagnosis Supply, Demand and Key Producers, 2023-2029

Page: 133

Published Date: 23 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Immuno-oncology Diagnosis market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Immuno-oncology Diagnosis demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Immuno-oncology Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immuno-oncology Diagnosis that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Immuno-oncology Diagnosis total market, 2018-2029, (USD Million)
Global Immuno-oncology Diagnosis total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Immuno-oncology Diagnosis total market, key domestic companies and share, (USD Million)
Global Immuno-oncology Diagnosis revenue by player and market share 2018-2023, (USD Million)
Global Immuno-oncology Diagnosis total market by Type, CAGR, 2018-2029, (USD Million)
Global Immuno-oncology Diagnosis total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Immuno-oncology Diagnosis market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies, Aethlon Medical, Agena Bioscience, Angle plc, Apocell and ARUP Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immuno-oncology Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Immuno-oncology Diagnosis Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Immuno-oncology Diagnosis Market, Segmentation by Type
    PCR
    NGS
    Immunoassay

Global Immuno-oncology Diagnosis Market, Segmentation by Application
    Research
    Diagnostics

Companies Profiled:
    10x Genomics
    Abbott Laboratories
    Abcam
    Adaptive Biotechnologies
    Aethlon Medical
    Agena Bioscience
    Angle plc
    Apocell
    ARUP Laboratories
    Beckman Coulter
    Becton Dickinson
    Bioarray Genetics
    BioCartis
    Biocept
    Biodesix Inc
    BioFluidica
    BioGenex 40 bioMérieux
    Bio-Rad
    Bio-Techne
    Bristol-Myers Squibb
    Cancer Genetics
    Caris Molecular Diagnostics
    CellMax Life
    Charles River Laboratories
    Chronix Biomedical
    Circulogene
    Clearbridge BioMedics
    Clinical Genomics
    Pfizer
    Promega
    Protagen Diagnostics
    Qiagen
    Quanterix
    Rarecells SAS
    Roche Diagnostics
    Siemens

Key Questions Answered
1. How big is the global Immuno-oncology Diagnosis market?
2. What is the demand of the global Immuno-oncology Diagnosis market?
3. What is the year over year growth of the global Immuno-oncology Diagnosis market?
4. What is the total value of the global Immuno-oncology Diagnosis market?
5. Who are the major players in the global Immuno-oncology Diagnosis market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Immuno-oncology Diagnosis Introduction
    1.2 World Immuno-oncology Diagnosis Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Immuno-oncology Diagnosis Total Market by Region (by Headquarter Location)
        1.3.1 World Immuno-oncology Diagnosis Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Immuno-oncology Diagnosis Market Size (2018-2029)
        1.3.3 China Immuno-oncology Diagnosis Market Size (2018-2029)
        1.3.4 Europe Immuno-oncology Diagnosis Market Size (2018-2029)
        1.3.5 Japan Immuno-oncology Diagnosis Market Size (2018-2029)
        1.3.6 South Korea Immuno-oncology Diagnosis Market Size (2018-2029)
        1.3.7 ASEAN Immuno-oncology Diagnosis Market Size (2018-2029)
        1.3.8 India Immuno-oncology Diagnosis Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Immuno-oncology Diagnosis Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Immuno-oncology Diagnosis Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Immuno-oncology Diagnosis Consumption Value (2018-2029)
    2.2 World Immuno-oncology Diagnosis Consumption Value by Region
        2.2.1 World Immuno-oncology Diagnosis Consumption Value by Region (2018-2023)
        2.2.2 World Immuno-oncology Diagnosis Consumption Value Forecast by Region (2024-2029)
    2.3 United States Immuno-oncology Diagnosis Consumption Value (2018-2029)
    2.4 China Immuno-oncology Diagnosis Consumption Value (2018-2029)
    2.5 Europe Immuno-oncology Diagnosis Consumption Value (2018-2029)
    2.6 Japan Immuno-oncology Diagnosis Consumption Value (2018-2029)
    2.7 South Korea Immuno-oncology Diagnosis Consumption Value (2018-2029)
    2.8 ASEAN Immuno-oncology Diagnosis Consumption Value (2018-2029)
    2.9 India Immuno-oncology Diagnosis Consumption Value (2018-2029)

3 World Immuno-oncology Diagnosis Companies Competitive Analysis
    3.1 World Immuno-oncology Diagnosis Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Immuno-oncology Diagnosis Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Immuno-oncology Diagnosis in 2022
        3.2.3 Global Concentration Ratios (CR8) for Immuno-oncology Diagnosis in 2022
    3.3 Immuno-oncology Diagnosis Company Evaluation Quadrant
    3.4 Immuno-oncology Diagnosis Market: Overall Company Footprint Analysis
        3.4.1 Immuno-oncology Diagnosis Market: Region Footprint
        3.4.2 Immuno-oncology Diagnosis Market: Company Product Type Footprint
        3.4.3 Immuno-oncology Diagnosis Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Immuno-oncology Diagnosis Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Immuno-oncology Diagnosis Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Immuno-oncology Diagnosis Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Immuno-oncology Diagnosis Consumption Value Comparison
        4.2.1 United States VS China: Immuno-oncology Diagnosis Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Immuno-oncology Diagnosis Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Immuno-oncology Diagnosis Companies and Market Share, 2018-2023
        4.3.1 United States Based Immuno-oncology Diagnosis Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Immuno-oncology Diagnosis Revenue, (2018-2023)
    4.4 China Based Companies Immuno-oncology Diagnosis Revenue and Market Share, 2018-2023
        4.4.1 China Based Immuno-oncology Diagnosis Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Immuno-oncology Diagnosis Revenue, (2018-2023)
    4.5 Rest of World Based Immuno-oncology Diagnosis Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Immuno-oncology Diagnosis Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Immuno-oncology Diagnosis Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Immuno-oncology Diagnosis Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 PCR
        5.2.2 NGS
        5.2.3 Immunoassay
    5.3 Market Segment by Type
        5.3.1 World Immuno-oncology Diagnosis Market Size by Type (2018-2023)
        5.3.2 World Immuno-oncology Diagnosis Market Size by Type (2024-2029)
        5.3.3 World Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Immuno-oncology Diagnosis Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Research
        6.2.2 Diagnostics
    6.3 Market Segment by Application
        6.3.1 World Immuno-oncology Diagnosis Market Size by Application (2018-2023)
        6.3.2 World Immuno-oncology Diagnosis Market Size by Application (2024-2029)
        6.3.3 World Immuno-oncology Diagnosis Market Size by Application (2018-2029)

7 Company Profiles
    7.1 10x Genomics
        7.1.1 10x Genomics Details
        7.1.2 10x Genomics Major Business
        7.1.3 10x Genomics Immuno-oncology Diagnosis Product and Services
        7.1.4 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 10x Genomics Recent Developments/Updates
        7.1.6 10x Genomics Competitive Strengths & Weaknesses
    7.2 Abbott Laboratories
        7.2.1 Abbott Laboratories Details
        7.2.2 Abbott Laboratories Major Business
        7.2.3 Abbott Laboratories Immuno-oncology Diagnosis Product and Services
        7.2.4 Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Abbott Laboratories Recent Developments/Updates
        7.2.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.3 Abcam
        7.3.1 Abcam Details
        7.3.2 Abcam Major Business
        7.3.3 Abcam Immuno-oncology Diagnosis Product and Services
        7.3.4 Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Abcam Recent Developments/Updates
        7.3.6 Abcam Competitive Strengths & Weaknesses
    7.4 Adaptive Biotechnologies
        7.4.1 Adaptive Biotechnologies Details
        7.4.2 Adaptive Biotechnologies Major Business
        7.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Product and Services
        7.4.4 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Adaptive Biotechnologies Recent Developments/Updates
        7.4.6 Adaptive Biotechnologies Competitive Strengths & Weaknesses
    7.5 Aethlon Medical
        7.5.1 Aethlon Medical Details
        7.5.2 Aethlon Medical Major Business
        7.5.3 Aethlon Medical Immuno-oncology Diagnosis Product and Services
        7.5.4 Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Aethlon Medical Recent Developments/Updates
        7.5.6 Aethlon Medical Competitive Strengths & Weaknesses
    7.6 Agena Bioscience
        7.6.1 Agena Bioscience Details
        7.6.2 Agena Bioscience Major Business
        7.6.3 Agena Bioscience Immuno-oncology Diagnosis Product and Services
        7.6.4 Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Agena Bioscience Recent Developments/Updates
        7.6.6 Agena Bioscience Competitive Strengths & Weaknesses
    7.7 Angle plc
        7.7.1 Angle plc Details
        7.7.2 Angle plc Major Business
        7.7.3 Angle plc Immuno-oncology Diagnosis Product and Services
        7.7.4 Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Angle plc Recent Developments/Updates
        7.7.6 Angle plc Competitive Strengths & Weaknesses
    7.8 Apocell
        7.8.1 Apocell Details
        7.8.2 Apocell Major Business
        7.8.3 Apocell Immuno-oncology Diagnosis Product and Services
        7.8.4 Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Apocell Recent Developments/Updates
        7.8.6 Apocell Competitive Strengths & Weaknesses
    7.9 ARUP Laboratories
        7.9.1 ARUP Laboratories Details
        7.9.2 ARUP Laboratories Major Business
        7.9.3 ARUP Laboratories Immuno-oncology Diagnosis Product and Services
        7.9.4 ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 ARUP Laboratories Recent Developments/Updates
        7.9.6 ARUP Laboratories Competitive Strengths & Weaknesses
    7.10 Beckman Coulter
        7.10.1 Beckman Coulter Details
        7.10.2 Beckman Coulter Major Business
        7.10.3 Beckman Coulter Immuno-oncology Diagnosis Product and Services
        7.10.4 Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Beckman Coulter Recent Developments/Updates
        7.10.6 Beckman Coulter Competitive Strengths & Weaknesses
    7.11 Becton Dickinson
        7.11.1 Becton Dickinson Details
        7.11.2 Becton Dickinson Major Business
        7.11.3 Becton Dickinson Immuno-oncology Diagnosis Product and Services
        7.11.4 Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Becton Dickinson Recent Developments/Updates
        7.11.6 Becton Dickinson Competitive Strengths & Weaknesses
    7.12 Bioarray Genetics
        7.12.1 Bioarray Genetics Details
        7.12.2 Bioarray Genetics Major Business
        7.12.3 Bioarray Genetics Immuno-oncology Diagnosis Product and Services
        7.12.4 Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Bioarray Genetics Recent Developments/Updates
        7.12.6 Bioarray Genetics Competitive Strengths & Weaknesses
    7.13 BioCartis
        7.13.1 BioCartis Details
        7.13.2 BioCartis Major Business
        7.13.3 BioCartis Immuno-oncology Diagnosis Product and Services
        7.13.4 BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 BioCartis Recent Developments/Updates
        7.13.6 BioCartis Competitive Strengths & Weaknesses
    7.14 Biocept
        7.14.1 Biocept Details
        7.14.2 Biocept Major Business
        7.14.3 Biocept Immuno-oncology Diagnosis Product and Services
        7.14.4 Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Biocept Recent Developments/Updates
        7.14.6 Biocept Competitive Strengths & Weaknesses
    7.15 Biodesix Inc
        7.15.1 Biodesix Inc Details
        7.15.2 Biodesix Inc Major Business
        7.15.3 Biodesix Inc Immuno-oncology Diagnosis Product and Services
        7.15.4 Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Biodesix Inc Recent Developments/Updates
        7.15.6 Biodesix Inc Competitive Strengths & Weaknesses
    7.16 BioFluidica
        7.16.1 BioFluidica Details
        7.16.2 BioFluidica Major Business
        7.16.3 BioFluidica Immuno-oncology Diagnosis Product and Services
        7.16.4 BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 BioFluidica Recent Developments/Updates
        7.16.6 BioFluidica Competitive Strengths & Weaknesses
    7.17 BioGenex 40 bioMérieux
        7.17.1 BioGenex 40 bioMérieux Details
        7.17.2 BioGenex 40 bioMérieux Major Business
        7.17.3 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product and Services
        7.17.4 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 BioGenex 40 bioMérieux Recent Developments/Updates
        7.17.6 BioGenex 40 bioMérieux Competitive Strengths & Weaknesses
    7.18 Bio-Rad
        7.18.1 Bio-Rad Details
        7.18.2 Bio-Rad Major Business
        7.18.3 Bio-Rad Immuno-oncology Diagnosis Product and Services
        7.18.4 Bio-Rad Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Bio-Rad Recent Developments/Updates
        7.18.6 Bio-Rad Competitive Strengths & Weaknesses
    7.19 Bio-Techne
        7.19.1 Bio-Techne Details
        7.19.2 Bio-Techne Major Business
        7.19.3 Bio-Techne Immuno-oncology Diagnosis Product and Services
        7.19.4 Bio-Techne Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Bio-Techne Recent Developments/Updates
        7.19.6 Bio-Techne Competitive Strengths & Weaknesses
    7.20 Bristol-Myers Squibb
        7.20.1 Bristol-Myers Squibb Details
        7.20.2 Bristol-Myers Squibb Major Business
        7.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Product and Services
        7.20.4 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Bristol-Myers Squibb Recent Developments/Updates
        7.20.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.21 Cancer Genetics
        7.21.1 Cancer Genetics Details
        7.21.2 Cancer Genetics Major Business
        7.21.3 Cancer Genetics Immuno-oncology Diagnosis Product and Services
        7.21.4 Cancer Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.21.5 Cancer Genetics Recent Developments/Updates
        7.21.6 Cancer Genetics Competitive Strengths & Weaknesses
    7.22 Caris Molecular Diagnostics
        7.22.1 Caris Molecular Diagnostics Details
        7.22.2 Caris Molecular Diagnostics Major Business
        7.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Product and Services
        7.22.4 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.22.5 Caris Molecular Diagnostics Recent Developments/Updates
        7.22.6 Caris Molecular Diagnostics Competitive Strengths & Weaknesses
    7.23 CellMax Life
        7.23.1 CellMax Life Details
        7.23.2 CellMax Life Major Business
        7.23.3 CellMax Life Immuno-oncology Diagnosis Product and Services
        7.23.4 CellMax Life Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.23.5 CellMax Life Recent Developments/Updates
        7.23.6 CellMax Life Competitive Strengths & Weaknesses
    7.24 Charles River Laboratories
        7.24.1 Charles River Laboratories Details
        7.24.2 Charles River Laboratories Major Business
        7.24.3 Charles River Laboratories Immuno-oncology Diagnosis Product and Services
        7.24.4 Charles River Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.24.5 Charles River Laboratories Recent Developments/Updates
        7.24.6 Charles River Laboratories Competitive Strengths & Weaknesses
    7.25 Chronix Biomedical
        7.25.1 Chronix Biomedical Details
        7.25.2 Chronix Biomedical Major Business
        7.25.3 Chronix Biomedical Immuno-oncology Diagnosis Product and Services
        7.25.4 Chronix Biomedical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.25.5 Chronix Biomedical Recent Developments/Updates
        7.25.6 Chronix Biomedical Competitive Strengths & Weaknesses
    7.26 Circulogene
        7.26.1 Circulogene Details
        7.26.2 Circulogene Major Business
        7.26.3 Circulogene Immuno-oncology Diagnosis Product and Services
        7.26.4 Circulogene Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.26.5 Circulogene Recent Developments/Updates
        7.26.6 Circulogene Competitive Strengths & Weaknesses
    7.27 Clearbridge BioMedics
        7.27.1 Clearbridge BioMedics Details
        7.27.2 Clearbridge BioMedics Major Business
        7.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Product and Services
        7.27.4 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.27.5 Clearbridge BioMedics Recent Developments/Updates
        7.27.6 Clearbridge BioMedics Competitive Strengths & Weaknesses
    7.28 Clinical Genomics
        7.28.1 Clinical Genomics Details
        7.28.2 Clinical Genomics Major Business
        7.28.3 Clinical Genomics Immuno-oncology Diagnosis Product and Services
        7.28.4 Clinical Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.28.5 Clinical Genomics Recent Developments/Updates
        7.28.6 Clinical Genomics Competitive Strengths & Weaknesses
    7.29 Pfizer
        7.29.1 Pfizer Details
        7.29.2 Pfizer Major Business
        7.29.3 Pfizer Immuno-oncology Diagnosis Product and Services
        7.29.4 Pfizer Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.29.5 Pfizer Recent Developments/Updates
        7.29.6 Pfizer Competitive Strengths & Weaknesses
    7.30 Promega
        7.30.1 Promega Details
        7.30.2 Promega Major Business
        7.30.3 Promega Immuno-oncology Diagnosis Product and Services
        7.30.4 Promega Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.30.5 Promega Recent Developments/Updates
        7.30.6 Promega Competitive Strengths & Weaknesses
    7.31 Protagen Diagnostics
        7.31.1 Protagen Diagnostics Details
        7.31.2 Protagen Diagnostics Major Business
        7.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Product and Services
        7.31.4 Protagen Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.31.5 Protagen Diagnostics Recent Developments/Updates
        7.31.6 Protagen Diagnostics Competitive Strengths & Weaknesses
    7.32 Qiagen
        7.32.1 Qiagen Details
        7.32.2 Qiagen Major Business
        7.32.3 Qiagen Immuno-oncology Diagnosis Product and Services
        7.32.4 Qiagen Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.32.5 Qiagen Recent Developments/Updates
        7.32.6 Qiagen Competitive Strengths & Weaknesses
    7.33 Quanterix
        7.33.1 Quanterix Details
        7.33.2 Quanterix Major Business
        7.33.3 Quanterix Immuno-oncology Diagnosis Product and Services
        7.33.4 Quanterix Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.33.5 Quanterix Recent Developments/Updates
        7.33.6 Quanterix Competitive Strengths & Weaknesses
    7.34 Rarecells SAS
        7.34.1 Rarecells SAS Details
        7.34.2 Rarecells SAS Major Business
        7.34.3 Rarecells SAS Immuno-oncology Diagnosis Product and Services
        7.34.4 Rarecells SAS Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.34.5 Rarecells SAS Recent Developments/Updates
        7.34.6 Rarecells SAS Competitive Strengths & Weaknesses
    7.35 Roche Diagnostics
        7.35.1 Roche Diagnostics Details
        7.35.2 Roche Diagnostics Major Business
        7.35.3 Roche Diagnostics Immuno-oncology Diagnosis Product and Services
        7.35.4 Roche Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.35.5 Roche Diagnostics Recent Developments/Updates
        7.35.6 Roche Diagnostics Competitive Strengths & Weaknesses
    7.36 Siemens
        7.36.1 Siemens Details
        7.36.2 Siemens Major Business
        7.36.3 Siemens Immuno-oncology Diagnosis Product and Services
        7.36.4 Siemens Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        7.36.5 Siemens Recent Developments/Updates
        7.36.6 Siemens Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Immuno-oncology Diagnosis Industry Chain
    8.2 Immuno-oncology Diagnosis Upstream Analysis
    8.3 Immuno-oncology Diagnosis Midstream Analysis
    8.4 Immuno-oncology Diagnosis Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Immuno-oncology Diagnosis Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Immuno-oncology Diagnosis Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Immuno-oncology Diagnosis Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Immuno-oncology Diagnosis Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Immuno-oncology Diagnosis Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Immuno-oncology Diagnosis Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Immuno-oncology Diagnosis Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Immuno-oncology Diagnosis Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Immuno-oncology Diagnosis Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Immuno-oncology Diagnosis Players in 2022
    Table 12. World Immuno-oncology Diagnosis Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Immuno-oncology Diagnosis Company Evaluation Quadrant
    Table 14. Head Office of Key Immuno-oncology Diagnosis Player
    Table 15. Immuno-oncology Diagnosis Market: Company Product Type Footprint
    Table 16. Immuno-oncology Diagnosis Market: Company Product Application Footprint
    Table 17. Immuno-oncology Diagnosis Mergers & Acquisitions Activity
    Table 18. United States VS China Immuno-oncology Diagnosis Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Immuno-oncology Diagnosis Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Immuno-oncology Diagnosis Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Immuno-oncology Diagnosis Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Immuno-oncology Diagnosis Revenue Market Share (2018-2023)
    Table 23. China Based Immuno-oncology Diagnosis Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Immuno-oncology Diagnosis Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Immuno-oncology Diagnosis Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Immuno-oncology Diagnosis Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Immuno-oncology Diagnosis Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Immuno-oncology Diagnosis Revenue Market Share (2018-2023)
    Table 29. World Immuno-oncology Diagnosis Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Immuno-oncology Diagnosis Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (USD Million)
    Table 35. 10x Genomics Basic Information, Area Served and Competitors
    Table 36. 10x Genomics Major Business
    Table 37. 10x Genomics Immuno-oncology Diagnosis Product and Services
    Table 38. 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. 10x Genomics Recent Developments/Updates
    Table 40. 10x Genomics Competitive Strengths & Weaknesses
    Table 41. Abbott Laboratories Basic Information, Area Served and Competitors
    Table 42. Abbott Laboratories Major Business
    Table 43. Abbott Laboratories Immuno-oncology Diagnosis Product and Services
    Table 44. Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Abbott Laboratories Recent Developments/Updates
    Table 46. Abbott Laboratories Competitive Strengths & Weaknesses
    Table 47. Abcam Basic Information, Area Served and Competitors
    Table 48. Abcam Major Business
    Table 49. Abcam Immuno-oncology Diagnosis Product and Services
    Table 50. Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Abcam Recent Developments/Updates
    Table 52. Abcam Competitive Strengths & Weaknesses
    Table 53. Adaptive Biotechnologies Basic Information, Area Served and Competitors
    Table 54. Adaptive Biotechnologies Major Business
    Table 55. Adaptive Biotechnologies Immuno-oncology Diagnosis Product and Services
    Table 56. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Adaptive Biotechnologies Recent Developments/Updates
    Table 58. Adaptive Biotechnologies Competitive Strengths & Weaknesses
    Table 59. Aethlon Medical Basic Information, Area Served and Competitors
    Table 60. Aethlon Medical Major Business
    Table 61. Aethlon Medical Immuno-oncology Diagnosis Product and Services
    Table 62. Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Aethlon Medical Recent Developments/Updates
    Table 64. Aethlon Medical Competitive Strengths & Weaknesses
    Table 65. Agena Bioscience Basic Information, Area Served and Competitors
    Table 66. Agena Bioscience Major Business
    Table 67. Agena Bioscience Immuno-oncology Diagnosis Product and Services
    Table 68. Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Agena Bioscience Recent Developments/Updates
    Table 70. Agena Bioscience Competitive Strengths & Weaknesses
    Table 71. Angle plc Basic Information, Area Served and Competitors
    Table 72. Angle plc Major Business
    Table 73. Angle plc Immuno-oncology Diagnosis Product and Services
    Table 74. Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Angle plc Recent Developments/Updates
    Table 76. Angle plc Competitive Strengths & Weaknesses
    Table 77. Apocell Basic Information, Area Served and Competitors
    Table 78. Apocell Major Business
    Table 79. Apocell Immuno-oncology Diagnosis Product and Services
    Table 80. Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Apocell Recent Developments/Updates
    Table 82. Apocell Competitive Strengths & Weaknesses
    Table 83. ARUP Laboratories Basic Information, Area Served and Competitors
    Table 84. ARUP Laboratories Major Business
    Table 85. ARUP Laboratories Immuno-oncology Diagnosis Product and Services
    Table 86. ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. ARUP Laboratories Recent Developments/Updates
    Table 88. ARUP Laboratories Competitive Strengths & Weaknesses
    Table 89. Beckman Coulter Basic Information, Area Served and Competitors
    Table 90. Beckman Coulter Major Business
    Table 91. Beckman Coulter Immuno-oncology Diagnosis Product and Services
    Table 92. Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Beckman Coulter Recent Developments/Updates
    Table 94. Beckman Coulter Competitive Strengths & Weaknesses
    Table 95. Becton Dickinson Basic Information, Area Served and Competitors
    Table 96. Becton Dickinson Major Business
    Table 97. Becton Dickinson Immuno-oncology Diagnosis Product and Services
    Table 98. Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Becton Dickinson Recent Developments/Updates
    Table 100. Becton Dickinson Competitive Strengths & Weaknesses
    Table 101. Bioarray Genetics Basic Information, Area Served and Competitors
    Table 102. Bioarray Genetics Major Business
    Table 103. Bioarray Genetics Immuno-oncology Diagnosis Product and Services
    Table 104. Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Bioarray Genetics Recent Developments/Updates
    Table 106. Bioarray Genetics Competitive Strengths & Weaknesses
    Table 107. BioCartis Basic Information, Area Served and Competitors
    Table 108. BioCartis Major Business
    Table 109. BioCartis Immuno-oncology Diagnosis Product and Services
    Table 110. BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. BioCartis Recent Developments/Updates
    Table 112. BioCartis Competitive Strengths & Weaknesses
    Table 113. Biocept Basic Information, Area Served and Competitors
    Table 114. Biocept Major Business
    Table 115. Biocept Immuno-oncology Diagnosis Product and Services
    Table 116. Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Biocept Recent Developments/Updates
    Table 118. Biocept Competitive Strengths & Weaknesses
    Table 119. Biodesix Inc Basic Information, Area Served and Competitors
    Table 120. Biodesix Inc Major Business
    Table 121. Biodesix Inc Immuno-oncology Diagnosis Product and Services
    Table 122. Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Biodesix Inc Recent Developments/Updates
    Table 124. Biodesix Inc Competitive Strengths & Weaknesses
    Table 125. BioFluidica Basic Information, Area Served and Competitors
    Table 126. BioFluidica Major Business
    Table 127. BioFluidica Immuno-oncology Diagnosis Product and Services
    Table 128. BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. BioFluidica Recent Developments/Updates
    Table 130. BioFluidica Competitive Strengths & Weaknesses
    Table 131. BioGenex 40 bioMérieux Basic Information, Area Served and Competitors
    Table 132. BioGenex 40 bioMérieux Major Business
    Table 133. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product and Services
    Table 134. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. BioGenex 40 bioMérieux Recent Developments/Updates
    Table 136. BioGenex 40 bioMérieux Competitive Strengths & Weaknesses
    Table 137. Bio-Rad Basic Information, Area Served and Competitors
    Table 138. Bio-Rad Major Business
    Table 139. Bio-Rad Immuno-oncology Diagnosis Product and Services
    Table 140. Bio-Rad Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Bio-Rad Recent Developments/Updates
    Table 142. Bio-Rad Competitive Strengths & Weaknesses
    Table 143. Bio-Techne Basic Information, Area Served and Competitors
    Table 144. Bio-Techne Major Business
    Table 145. Bio-Techne Immuno-oncology Diagnosis Product and Services
    Table 146. Bio-Techne Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Bio-Techne Recent Developments/Updates
    Table 148. Bio-Techne Competitive Strengths & Weaknesses
    Table 149. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 150. Bristol-Myers Squibb Major Business
    Table 151. Bristol-Myers Squibb Immuno-oncology Diagnosis Product and Services
    Table 152. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 153. Bristol-Myers Squibb Recent Developments/Updates
    Table 154. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 155. Cancer Genetics Basic Information, Area Served and Competitors
    Table 156. Cancer Genetics Major Business
    Table 157. Cancer Genetics Immuno-oncology Diagnosis Product and Services
    Table 158. Cancer Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 159. Cancer Genetics Recent Developments/Updates
    Table 160. Cancer Genetics Competitive Strengths & Weaknesses
    Table 161. Caris Molecular Diagnostics Basic Information, Area Served and Competitors
    Table 162. Caris Molecular Diagnostics Major Business
    Table 163. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product and Services
    Table 164. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 165. Caris Molecular Diagnostics Recent Developments/Updates
    Table 166. Caris Molecular Diagnostics Competitive Strengths & Weaknesses
    Table 167. CellMax Life Basic Information, Area Served and Competitors
    Table 168. CellMax Life Major Business
    Table 169. CellMax Life Immuno-oncology Diagnosis Product and Services
    Table 170. CellMax Life Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 171. CellMax Life Recent Developments/Updates
    Table 172. CellMax Life Competitive Strengths & Weaknesses
    Table 173. Charles River Laboratories Basic Information, Area Served and Competitors
    Table 174. Charles River Laboratories Major Business
    Table 175. Charles River Laboratories Immuno-oncology Diagnosis Product and Services
    Table 176. Charles River Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 177. Charles River Laboratories Recent Developments/Updates
    Table 178. Charles River Laboratories Competitive Strengths & Weaknesses
    Table 179. Chronix Biomedical Basic Information, Area Served and Competitors
    Table 180. Chronix Biomedical Major Business
    Table 181. Chronix Biomedical Immuno-oncology Diagnosis Product and Services
    Table 182. Chronix Biomedical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 183. Chronix Biomedical Recent Developments/Updates
    Table 184. Chronix Biomedical Competitive Strengths & Weaknesses
    Table 185. Circulogene Basic Information, Area Served and Competitors
    Table 186. Circulogene Major Business
    Table 187. Circulogene Immuno-oncology Diagnosis Product and Services
    Table 188. Circulogene Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 189. Circulogene Recent Developments/Updates
    Table 190. Circulogene Competitive Strengths & Weaknesses
    Table 191. Clearbridge BioMedics Basic Information, Area Served and Competitors
    Table 192. Clearbridge BioMedics Major Business
    Table 193. Clearbridge BioMedics Immuno-oncology Diagnosis Product and Services
    Table 194. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 195. Clearbridge BioMedics Recent Developments/Updates
    Table 196. Clearbridge BioMedics Competitive Strengths & Weaknesses
    Table 197. Clinical Genomics Basic Information, Area Served and Competitors
    Table 198. Clinical Genomics Major Business
    Table 199. Clinical Genomics Immuno-oncology Diagnosis Product and Services
    Table 200. Clinical Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 201. Clinical Genomics Recent Developments/Updates
    Table 202. Clinical Genomics Competitive Strengths & Weaknesses
    Table 203. Pfizer Basic Information, Area Served and Competitors
    Table 204. PfizerMajor Business
    Table 205. Pfizer Immuno-oncology Diagnosis Product and Services
    Table 206. Pfizer Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 207. Pfizer Recent Developments/Updates
    Table 208. Pfizer Competitive Strengths & Weaknesses
    Table 209. Promega Basic Information, Area Served and Competitors
    Table 210. Promega Major Business
    Table 211. Promega Immuno-oncology Diagnosis Product and Services
    Table 212. Promega Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 213. Promega Recent Developments/Updates
    Table 214. Promega Competitive Strengths & Weaknesses
    Table 215. Protagen Diagnostics Basic Information, Area Served and Competitors
    Table 216. Protagen Diagnostics Major Business
    Table 217. Protagen Diagnostics Immuno-oncology Diagnosis Product and Services
    Table 218. Protagen Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 219. Protagen Diagnostics Recent Developments/Updates
    Table 220. Protagen Diagnostics Competitive Strengths & Weaknesses
    Table 221. Qiagen Basic Information, Area Served and Competitors
    Table 222. Qiagen Major Business
    Table 223. Qiagen Immuno-oncology Diagnosis Product and Services
    Table 224. Qiagen Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 225. Qiagen Recent Developments/Updates
    Table 226. Qiagen Competitive Strengths & Weaknesses
    Table 227. Quanterix Basic Information, Area Served and Competitors
    Table 228. Quanterix Major Business
    Table 229. Quanterix Immuno-oncology Diagnosis Product and Services
    Table 230. Quanterix Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 231. Quanterix Recent Developments/Updates
    Table 232. Quanterix Competitive Strengths & Weaknesses
    Table 233. Rarecells SAS Basic Information, Area Served and Competitors
    Table 234. Rarecells SAS Major Business
    Table 235. Rarecells SAS Immuno-oncology Diagnosis Product and Services
    Table 236. Rarecells SAS Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 237. Rarecells SAS Recent Developments/Updates
    Table 238. Rarecells SAS Competitive Strengths & Weaknesses
    Table 239. Roche Diagnostics Basic Information, Area Served and Competitors
    Table 240. Roche Diagnostics Major Business
    Table 241. Roche Diagnostics Immuno-oncology Diagnosis Product and Services
    Table 242. Roche Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 243. Roche Diagnostics Recent Developments/Updates
    Table 244. Siemens Basic Information, Area Served and Competitors
    Table 245. Siemens Major Business
    Table 246. Siemens Immuno-oncology Diagnosis Product and Services
    Table 247. Siemens Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 248. Global Key Players of Immuno-oncology Diagnosis Upstream (Raw Materials)
    Table 249. Immuno-oncology Diagnosis Typical Customers
List of Figure
    Figure 1. Immuno-oncology Diagnosis Picture
    Figure 2. World Immuno-oncology Diagnosis Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Immuno-oncology Diagnosis Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Immuno-oncology Diagnosis Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Immuno-oncology Diagnosis Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Immuno-oncology Diagnosis Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Immuno-oncology Diagnosis Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Immuno-oncology Diagnosis Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Immuno-oncology Diagnosis Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Immuno-oncology Diagnosis Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Immuno-oncology Diagnosis Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Immuno-oncology Diagnosis Revenue (2018-2029) & (USD Million)
    Figure 13. Immuno-oncology Diagnosis Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Immuno-oncology Diagnosis Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Immuno-oncology Diagnosis by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Immuno-oncology Diagnosis Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Immuno-oncology Diagnosis Markets in 2022
    Figure 27. United States VS China: Immuno-oncology Diagnosis Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Immuno-oncology Diagnosis Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Immuno-oncology Diagnosis Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Immuno-oncology Diagnosis Market Size Market Share by Type in 2022
    Figure 31. PCR
    Figure 32. NGS
    Figure 33. Immunoassay
    Figure 34. World Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2029)
    Figure 35. World Immuno-oncology Diagnosis Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Immuno-oncology Diagnosis Market Size Market Share by Application in 2022
    Figure 37. Research
    Figure 38. Diagnostics
    Figure 39. Immuno-oncology Diagnosis Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

10x Genomics
Abbott Laboratories
Abcam
Adaptive Biotechnologies
Aethlon Medical
Agena Bioscience
Angle plc
Apocell
ARUP Laboratories
Beckman Coulter
Becton Dickinson
Bioarray Genetics
BioCartis
Biocept
Biodesix Inc
BioFluidica
BioGenex 40 bioMérieux
Bio-Rad
Bio-Techne
Bristol-Myers Squibb
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Charles River Laboratories
Chronix Biomedical
Circulogene
Clearbridge BioMedics
Clinical Genomics
Pfizer
Promega
Protagen Diagnostics
Qiagen
Quanterix
Rarecells SAS
Roche Diagnostics
Siemens

Related Reports

Global Immuno-oncology Diagnosis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Immuno-oncology Diagnosis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Immuno-oncology Diagnosis market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Immuno-oncology Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Immuno-oncology Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 03 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Immuno-oncology Diagnosis market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Immuno-oncology Diagnosis

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>